Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model

Thrombosis and Haemostasis

Volumn 77, Issue 6, 1997, Pages 1174-1178

  Perkins, W R ^a   Vaughan, D E ^b,d   Plavin, S R ^b   Daley, W L ^b   Rauch, J ^c   Lee, L ^a   Janoff, A S ^a  

^a Liposome Company Incorporated   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; LIPOSOME; SODIUM CHLORIDE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; ENCAPSULATION; IMMUNIZATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE;

EID: 0030840053     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656133     Document Type: Article

References (27)

1. De Wood DA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocantial infarction. New Engl J Med 1980; 303: 897-902.
2. Gosage JR. Acute myocardial infarction: reperfusion strategies. Chest 1994; 106: 1851-56.
3. Habib GB. Current status of thrombolysis in acute myocardial infarction. Chest 1995; 107: 225-32.
4. Verstraete M, Lijnen HR. Novel thrombolytic agents. Cardiovas Drugs Ther 1994; 8: 801-12.
5. Verstraete M. Advances in thrombolytic therapy. Cardiovas Drugs Ther 1992; 6: 111-24.
6. Lijnen HR, Collen D. Strategies for the improvement of thrombolytic agents. Thromb Haemost 1991; 66: 88-110.
7. Caride, VJ, Zaret, BL. Liposome accumulation in regions of experimental myocardial infarction. Science 1977; 198: 735-8.
8. 1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model. Circulation 1995; 92: 935-43.
9. Nguyen PD, O'Rear EA, Johnson AE, Lu R, Fung BM. Thrombolysis using liposomal-encapsulated streptokinase: an in vitro study. Proc Soc Exp Biol Med 1989; 192: 261-9.
10. Heeremans JLM, Prevost R, Bekkers MEA, Los P, Emeis JJ, Kluft C, Crommelin DJA. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Thromb Haemost 1995; 73: 488-94.
11. Nguyen PD, O'Rear EA, Johnson AE, Patterson E, Whitsett TL, Bhakta R. Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase. Circulation Res 1990; 66: 875-8.
12. Grignani G, Zucchella M, Brocchieri A, Saporiti A. Current concepts in coronary thrombolysis. Haematologica 1994; 79: 475-82.
13. Ahl PL, Chen L, Perkins WR, Minchey SR, Boni LT, Taraschi TF, Janoff AS. Interdigitation-fusion: a new method for producing lipid vesicles of high internal volume. Biochim Biophys Acta 1994; 1195: 237-44.
14. Perkins WR, Minchey SR, Ahl PL. Janoff AS. The determination of liposome captured volume. Chem Phys Lipids 1993; 64: 197-217.
15. Chen PS Jr, Toribara TY, Warner H. Microdetermination of phosphorus. Anal Chem 1956; 28: 1756-8.
16. Jackson KW, Esmon N, Tang J. Streptokinase and staphylokinase. Methods in Enzymology (Ed. Perlman GE, Lorand L), Academic Press Inc., New York, 1980; 80: 387-94.
17. 1 accelerates thrombolysis by tissue plasminogen activator. Blood 1989; 73: 1213-7.
18. Ahl PL, Roberts P, Stevens R, Bhatia S, Ali S, Meers P, Janoff AS. Enhanced circulation-lifetime of DSPC liposomes: importance of complement opsonization and liposome aggregation. Biophys J 1997; 72: A309.
19. Vaughan DE, Van Houte E, Declerck PJ, Collen D. Streptokinase-induced platelet aggregation: prevalence and mechanism. Circulation 1991; 84: 84-91.
20. Reinish LW, Bally MB, Loughrey HC, Cullis PR. Interactions of liposomes and platelets. Thromb Haemost 1988; 60: 518-23.
21. Perkins WR, Minchey SR, Boni LT, Swenson CE, Popescu MC, Pasternack RF, Janoff AS. Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. Biochim Biophys Acta 1992; 1107: 271-82.
22. Doerschuk CM, Gie RP, Bally MB, Cullis PR, Reinish LW. Platelet distribution in rabbits following infusion of liposomes. Thromb Haemost 1989; 61: 392-6.
23. Handin, RI. Disorders of Platelets and Vessel Wall. In: Harrison's Principles of Internal Medicine. Wilson JD, Braunwald E. Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK (eds). McGraw-Hill, NY 1991: pp 1500-5.
24. Patel, HM. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit Rev Ther Drug Sys 1992; 9: 39-90.
25. Hsu MJ, Juliano RL. Interactions of liposomes with the reticuloendothelial system. II. Nonspecific and receptor mediated uptake of liposomes by mouse peritoneal macrophages. Biochim Biophys Acta 1982; 720: 411-9.
26. Fitzgerald DJ, Catella F, Roy L, Fitzgerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 1988; 77: 142-50.
27. Verstraete M, Vermylen J, Amery A, Vermylen C. Thrombolytic therapy with streptokinase. Brit Med J 1966; 1: 454-6.